BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37246841)

  • 1. Albumin administration in septic shock-Protocol for post-hoc analyses of data from a multicentre RCT.
    Meyhoff TS; Granholm A; Hjortrup PB; Sivapalan P; Lange T; Laake JH; Cronhjort M; Jakob SM; Cecconi M; Nalos M; Ostermann M; Malbrain MLNG; Møller MH; Perner A
    Acta Anaesthesiol Scand; 2023 Sep; 67(8):1128-1136. PubMed ID: 37246841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin use in patients with septic shock-Post-hoc analyses of an international randomised fluid trial.
    Meyhoff TS; Granholm A; Hjortrup PB; Sivapalan P; Lange T; Laake JH; Cronhjort M; Jakob SM; Cecconi M; Nalos M; Ostermann M; Malbrain MLNG; Møller MH; Perner A
    Acta Anaesthesiol Scand; 2024 Mar; 68(3):372-384. PubMed ID: 37975538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan.
    Meyhoff TS; Hjortrup PB; Møller MH; Wetterslev J; Lange T; Kjaer MN; Jonsson AB; Hjortsø CJS; Cronhjort M; Laake JH; Jakob SM; Nalos M; Pettilä V; van der Horst I; Ostermann M; Mouncey P; Rowan K; Cecconi M; Ferrer R; Malbrain MLNG; Ahlstedt C; Hoffmann S; Bestle MH; Nebrich L; Russell L; Vang M; Rasmussen ML; Sølling C; Rasmussen BS; Brøchner AC; Perner A
    Acta Anaesthesiol Scand; 2019 Oct; 63(9):1262-1271. PubMed ID: 31276193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled multicentre study of albumin replacement therapy in septic shock (ARISS): protocol for a randomized controlled trial.
    Sakr Y; Bauer M; Nierhaus A; Kluge S; Schumacher U; Putensen C; Fichtner F; Petros S; Scheer C; Jaschinski U; Tanev I; Jacob D; Weiler N; Schulze PC; Fiedler F; Kapfer B; Brunkhorst F; Lautenschlaeger I; Wartenberg K; Utzolino S; Briegel J; Moerer O; Bischoff P; Zarbock A; Quintel M; Gattinoni L;
    Trials; 2020 Dec; 21(1):1002. PubMed ID: 33287911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of restrictive fluid therapy on the time to resolution of hyperlactatemia in ICU patients with septic shock. A secondary post hoc analysis of the CLASSIC randomized trial.
    Ahlstedt C; Sivapalan P; Kriz M; Jacobson G; Sylvest Meyhoff T; Skov Kaas-Hansen B; Holm M; Hollenberg J; Nalos M; Rooijackers O; Hylander Møller M; Cronhjort M; Perner A; Grip J
    Intensive Care Med; 2024 May; 50(5):678-686. PubMed ID: 38598125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liberal versus conservative fluid therapy in adults and children with sepsis or septic shock.
    Li D; Li X; Cui W; Shen H; Zhu H; Xia Y
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD010593. PubMed ID: 30536956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative vs. liberal fluid therapy in septic shock - Protocol for secondary Bayesian analyses of the CLASSIC trial.
    Sivapalan P; Meyhoff TS; Hjortrup PB; Lange T; Møller MH; Perner A; Granholm A
    Acta Anaesthesiol Scand; 2022 Jul; 66(6):767-771. PubMed ID: 35338648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluids in Sepsis and Septic Shock (FISSH): protocol for a pilot randomised controlled trial.
    Rochwerg B; Millen T; Austin P; Zeller M; D'Aragon F; Jaeschke R; Masse MH; Mehta S; Lamontagne F; Meade M; Guyatt G; Cook DJ;
    BMJ Open; 2017 Jul; 7(7):e017602. PubMed ID: 28729329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cost-effectiveness Analysis of Albumin in Septic Shock: A Patient-level Data Analysis.
    Tigabu BM; Davari M; Kebriaeezadeh A; Mojtahedzadeh M; Sadeghi K; Najmeddin F; Jahangard-Rafsanjani Z
    Clin Ther; 2019 Nov; 41(11):2297-2307.e2. PubMed ID: 31668842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial.
    Hjortrup PB; Haase N; Bundgaard H; Thomsen SL; Winding R; Pettilä V; Aaen A; Lodahl D; Berthelsen RE; Christensen H; Madsen MB; Winkel P; Wetterslev J; Perner A; ;
    Intensive Care Med; 2016 Nov; 42(11):1695-1705. PubMed ID: 27686349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicountry survey of emergency and critical care medicine physicians' fluid resuscitation practices for adult patients with early septic shock.
    McIntyre L; Rowe BH; Walsh TS; Gray A; Arabi Y; Perner A; Gordon A; Marshall J; Cook D; Fox-Robichaud A; Bagshaw SM; Green R; Schweitzer I; Turgeon A; Zarychanski R; English S; Chassé M; Stiell I; Fergusson D;
    BMJ Open; 2016 Jul; 6(7):e010041. PubMed ID: 27388345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restrictive versus standard IV fluid therapy in adult ICU patients with septic shock-Bayesian analyses of the CLASSIC trial.
    Sivapalan P; Meyhoff TS; Hjortrup PB; Lange T; Kaas-Hansen BS; Kjaer MN; Laake JH; Cronhjort M; Jakob SM; Cecconi M; Nalos M; Ostermann M; Malbrain MLNG; Møller MH; Perner A; Granholm A
    Acta Anaesthesiol Scand; 2024 Feb; 68(2):236-246. PubMed ID: 37869991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
    Holst LB
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricted fluid bolus versus current practice in children with septic shock: the FiSh feasibility study and pilot RCT.
    Inwald D; Canter RR; Woolfall K; O'Hara CB; Mouncey PR; Zenasni Z; Hudson N; Saunders S; Carter A; Jones N; Lyttle MD; Nadel S; Peters MJ; Harrison DA; Rowan KM
    Health Technol Assess; 2018 Sep; 22(51):1-106. PubMed ID: 30238870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction of Intravenous Fluid in ICU Patients with Septic Shock.
    Meyhoff TS; Hjortrup PB; Wetterslev J; Sivapalan P; Laake JH; Cronhjort M; Jakob SM; Cecconi M; Nalos M; Ostermann M; Malbrain M; Pettilä V; Møller MH; Kjær MN; Lange T; Overgaard-Steensen C; Brand BA; Winther-Olesen M; White JO; Quist L; Westergaard B; Jonsson AB; Hjortsø CJS; Meier N; Jensen TS; Engstrøm J; Nebrich L; Andersen-Ranberg NC; Jensen JV; Joseph NA; Poulsen LM; Herløv LS; Sølling CG; Pedersen SK; Knudsen KK; Straarup TS; Vang ML; Bundgaard H; Rasmussen BS; Aagaard SR; Hildebrandt T; Russell L; Bestle MH; Schønemann-Lund M; Brøchner AC; Elvander CF; Hoffmann SKL; Rasmussen ML; Martin YK; Friberg FF; Seter H; Aslam TN; Ådnøy S; Seidel P; Strand K; Johnstad B; Joelsson-Alm E; Christensen J; Ahlstedt C; Pfortmueller CA; Siegemund M; Greco M; Raděj J; Kříž M; Gould DW; Rowan KM; Mouncey PR; Perner A;
    N Engl J Med; 2022 Jun; 386(26):2459-2470. PubMed ID: 35709019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term patient-important outcomes after septic shock: A protocol for 1-year follow-up of the CLASSIC trial.
    Kjaer MN; Meyhoff TS; Madsen MB; Hjortrup PB; Møller MH; Egerod I; Wetterslev J; Lange T; Cronhjort M; Laake JH; Jakob SM; Nalos M; Pettilä V; van der Horst ICC; Ostermann M; Mouncey P; Cecconi M; Ferrer R; Malbrain MLNG; Ahlstedt C; Hoffmann S; Bestle MH; Gyldensted L; Nebrich L; Russell L; Vang M; Sølling C; Brøchner AC; Rasmussen BS; Perner A
    Acta Anaesthesiol Scand; 2020 Mar; 64(3):410-416. PubMed ID: 31828753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock.
    Kjær MN; Meyhoff TS; Sivapalan P; Granholm A; Hjortrup PB; Madsen MB; Møller MH; Egerod I; Wetterslev J; Lange T; Cronhjort M; Laake JH; Jakob SM; Nalos M; Ostermann M; Gould D; Cecconi M; Malbrain MLNG; Ahlstedt C; Kiel LB; Bestle MH; Nebrich L; Hildebrandt T; Russell L; Vang M; Rasmussen ML; Sølling C; Brøchner AC; Krag M; Pfortmueller C; Kriz M; Siegemund M; Albano G; Aagaard SR; Bundgaard H; Crone V; Wichmann S; Johnstad B; Martin YK; Seidel P; Mårtensson J; Hollenberg J; Wistrand M; Donati A; Barbara E; Karvunidis T; Hollinger A; Carsetti A; Lumlertgul N; Joelsson-Alm E; Lambiris N; Aslam TN; Friberg FF; Vesterlund GK; Mortensen CB; Vestergaard SR; Caspersen SF; Jensen DB; Borup M; Rasmussen BS; Perner A
    Intensive Care Med; 2023 Jul; 49(7):820-830. PubMed ID: 37330928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocolised reduction of non-resuscitation fluids versus usual care in patients with septic shock (REDUSE): a protocol for a multicentre feasibility trial.
    Lindén A; Fisher J; Lilja G; Olsen MH; Sjövall F; Jungner M; Spångfors M; Samuelsson L; Oras J; Linder A; Unden J; Kander T; Lipcsey M; Nielsen N; Jakobsen JC; Bentzer P
    BMJ Open; 2023 Feb; 13(2):e065392. PubMed ID: 36854601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.